Novo Holdings Checkmate Pharmaceuticals, Inc. (CMPI) insider trading activity
Novo Holdings is > 10% Shareholder of Checkmate Pharmaceuticals, Inc.. Currently has a direct ownership of 2.16 Million shares of CMPI, which is worth approximately $22.7 Million. The most recent transaction as insider was on Feb 25, 2022, when has been sold 300 shares (Common Stock) at a price of $2.7 per share, resulting in proceeds of $810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.16M
0%
3M change
0%
12M change
Total Value Held
$22.7 Million
Novo Holdings Transaction History
Also insider at
NH
Novo Holdings
> 10% Shareholder
Hellerup, G7